LTR Pharma Limited (ASX:LTP)

LTR Pharma Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Net Income	-14.16	-5.59	-6.95	-1.45	-1.03
Depreciation & Amortization	0.01	0	-	-	-
Loss (Gain) on Equity Investments	1.04	0.06	-	-	-
Stock-Based Compensation	3.07	0.8	1.3	0.02	-
Other Operating Activities	0.03	0.02	0.01	0.02	0.01
Change in Accounts Receivable	-0.17	0.02	0.1	-0.03	-0.01
Change in Inventory	-0.55	-0.02	-	-	-
Change in Accounts Payable	-0.1	0.27	0.44	-0.09	0.46
Operating Cash Flow	-10.84	-4.44	-5.09	-1.54	-0.57
Operating Cash Flow Growth	-	-	-	-	-

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Capital Expenditures	-0.01	-0.01	-0	-0	-
Investment in Securities	-1.11	-0.18	-	-	-
Investing Cash Flow	-1.11	-0.19	-0	-0	-

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Issuance of Common Stock	-	35.5	7	1.45	2.34
Other Financing Activities	-	-2.13	-0.5	-0.07	-
Financing Cash Flow	-	33.37	6.5	1.38	2.34

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Foreign Exchange Rate Adjustments	-0.2	-0.03	-0.03	-0.02	-0.01
Net Cash Flow	-12.15	28.71	1.37	-0.18	1.76

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Free Cash Flow	-10.85	-4.45	-5.09	-1.54	-0.57
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Margin	-1498.07%	-294.96%	-10396.58%	-	-6258.86%
Free Cash Flow Per Share	-0.06	-0.03	-0.04	-0.01	-
Levered Free Cash Flow	-6.51	-2.75	-2.83	-1.35	-0.31
Unlevered Free Cash Flow	-6.51	-2.75	-2.83	-1.35	-0.31

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash Interest Paid	0	0	0	0	0
Cash Income Tax Paid	-	-	-	-	-0.01
Change in Working Capital	-0.82	0.27	0.54	-0.12	0.45

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 11, 2026

Data Sources Report a data error